Surge in Options Trading Volume for Key S&P 500 Stocks

Today, significant activity in options trading was observed within the S&P 500 index, particularly for several prominent companies. Moderna Inc (Symbol: MRNA) led the way with a total of 86,083 contracts traded, representing around 8.6 million underlying shares. This figure accounts for roughly 68.1% of MRNA’s average daily trading volume of 12.6 million shares over the past month.

The $45 strike call option expiring on March 21, 2025, saw a notably high volume with 22,809 contracts traded, equivalent to approximately 2.3 million underlying shares of MRNA. The chart below illustrates MRNA’s trading history over the past twelve months, highlighting the $45 strike in orange:

Willis Towers Watson Public Ltd Co (Symbol: WTW) also experienced substantial options trading with 3,408 contracts, representing about 340,800 underlying shares. This is approximately 58.1% of WTW’s average daily trading volume of 586,795 shares over the last month. The $290 strike put option, set to expire on April 17, 2025, saw notable activity with 784 contracts traded, amounting to around 78,400 underlying shares of WTW. Below is the chart depicting WTW’s trading history, with the $290 strike marked in orange:

Additionally, Discover Financial Services (Symbol: DFS) reported a trading volume of 11,845 contracts today, representing approximately 1.2 million underlying shares. This volume is 50.3% of DFS’s average daily trading volume of 2.4 million shares over the past month. The $150 strike put option expiring on April 17, 2025, recorded particularly high activity with 6,842 contracts traded, equal to about 684,200 underlying shares. The following chart displays DFS’s trading history, with the $150 strike highlighted:

For more options available for MRNA, WTW, or DFS, visit StockOptionsChannel.com.

Today’s Most Active Call & Put Options of the S&P 500 »

Also see:

• Institutional Holders of ADI
• AGFY Videos
• Institutional Holders of TYO

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.